Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T05:20:13.340Z Has data issue: false hasContentIssue false
  • English
  • Français

Completely Resistant Acinetobacter baumannii Strains

Published online by Cambridge University Press:  02 January 2015

Siham Mahgoub,
Jimi Ahmed and
Aaron E. Glatt
Siham Mahgoub
Affiliation:
Division of Infectious Diseases, St. Vincent Catholic Medical Centers of New York, Brooklyn/Queens Region, Jamaica, New York
Jimi Ahmed
Affiliation:
Department of Infection Control, St. Vincent Catholic Medical Centers of New York, Brooklyn/Queens Region, Jamaica, New York
Aaron E. Glatt*
Affiliation:
Division of Infectious Diseases, St. Vincent Catholic Medical Centers of New York, Brooklyn/Queens Region, Jamaica, New YorkDepartment of Infection Control, St. Vincent Catholic Medical Centers of New York, Brooklyn/Queens Region, Jamaica, New YorkNew York Medical College, Valhalla, New York
*
St. Vincent Catholic Medical Centers, Brooklyn/Queens Service Division, 88-25 153 Street, Suite 3-R, Jamaica, NY 11432
Get accessRights & Permissions [Opens in a new window]

Abstract

Nosocomially acquired completely resistant Acinetobacter baumannii strains are a major clinical concern. We identified completely resistant A. baumannii in 6 (4.9%) of 122 A. baumannii isolates in a retrospective chart review at two teaching hospitals. All of these patients had received broad-spectrum antibiotics and had severe underlying comorbid illnesses, long hospitalizations, or recent surgical procedures; 3 had been in the intensive care unit. Five (83%) of the 6 patients were older than 70 years. Only one death occurred. Strict infection control measures may limit further spread.

Information

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 8 , August 2002, pp. 477 - 479
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Koeleman, JG, Parlevliet, GA, Dijkshoorn, L, et al. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 1997;37:113–123.Google Scholar
2.Kaul, R, Burt, JA, Cork, L, et al. Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii. J Infect Dis 1996;174:1279–1287.CrossRefGoogle ScholarPubMed
3.Lortholary, O, Fagon, JY, Hoi, AB, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995;20:790–796.CrossRefGoogle ScholarPubMed
4.Husni, RN, Goldstein, LS, Arroliga, AC, et al. Risk factors for an outbreak of multi-drug resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378–1382.Google Scholar
5.Villers, D, Espaze, E, Coste-Burel, M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998;129:182–189.Google Scholar
6.Manikal, VM, Landman, D, Saurina, G, Oydna, E, Lai, H, Quale, J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: city-wide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101–106.Google Scholar
7.Baraibar, J, Correa, H, Mariscal, D, Gallego, M, Valles, J, Rello, J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997;112:1050–1054.CrossRefGoogle ScholarPubMed
8.Mulin, B, Talon, D, Viel, JF, et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1995;14:569–576.Google Scholar
9.Okpara, AU, Maswoswe, JJ. Emergence of multidrug-resistant isolates of Acinetobacter baumannii. American Journal of Hospital Pharmacy 1994; 51:2671–2675.Google Scholar
10.Garcia-Garmendia, JL, Ortiz-Leyba, C, Garnacho-Montero, J, et al. Mortality and the increased length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 1999;27:1794–1798.Google Scholar